Addus HomeCare (NASDAQ:ADUS) Downgraded to Buy at StockNews.com

StockNews.com cut shares of Addus HomeCare (NASDAQ:ADUS) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning.

Other equities research analysts have also issued research reports about the stock. TD Cowen boosted their price target on shares of Addus HomeCare from $119.00 to $128.00 and gave the company a buy rating in a report on Tuesday. Royal Bank of Canada restated an outperform rating and set a $102.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 29th. Barclays downgraded Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 target price on the stock. in a report on Tuesday, April 23rd. Oppenheimer raised their price target on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an outperform rating in a report on Friday, June 7th. Finally, Stephens upped their price objective on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an overweight rating in a research note on Friday, May 31st. One research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. According to MarketBeat, Addus HomeCare currently has an average rating of Moderate Buy and a consensus price target of $113.43.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $118.45 on Friday. The company has a market capitalization of $1.94 billion, a PE ratio of 29.39, a price-to-earnings-growth ratio of 2.28 and a beta of 1.02. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a fifty day moving average of $107.61 and a 200-day moving average of $98.98. Addus HomeCare has a one year low of $78.35 and a one year high of $119.98.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $0.97 by $0.24. The business had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. Addus HomeCare’s revenue was up 11.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.84 earnings per share. As a group, equities analysts anticipate that Addus HomeCare will post 4.36 EPS for the current fiscal year.

Insider Activity

In related news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 4.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ADUS. Principal Securities Inc. bought a new position in shares of Addus HomeCare in the fourth quarter valued at approximately $26,000. GAMMA Investing LLC bought a new position in Addus HomeCare in the 4th quarter worth $34,000. EntryPoint Capital LLC acquired a new position in Addus HomeCare during the 1st quarter worth $44,000. Assetmark Inc. lifted its position in Addus HomeCare by 33.3% during the 4th quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after acquiring an additional 443 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in Addus HomeCare during the third quarter valued at about $189,000. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.